Status:
ACTIVE_NOT_RECRUITING
Study on the Staging and Prognosis Model of Bladder Cancer
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborating Sponsors:
Suzhou Municipal Hospital
Yixing People's Hospital
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Firstly, we retrospectively gathered the patient information who compliant with the criteria from 2012 to 2023, encompassing basic information, clinical information, along with MRI images, blood/urine...
Eligibility Criteria
Inclusion
- 1\. Patients with bladder cancer in preoperative examination; 2. Gender is not limited; 3. Age≥ 18 years old; 4. Be able to provide MRI images, pathological data and laboratory examination data before the operation; 5. Agree to provide basic personal clinical information and pathological and imaging data for scientific research use, and sign the informed consent form; 6. Agree to provide monitoring results during follow-up recurrence monitoring;
Exclusion
- 1\. Incomplete clinicopathological data; 2. Combined with upper tract urothelial carcinoma or previously diagnosed upper tract urothelial carcinoma; 3. Is participating in the rest of the clinical studies; Unable to cooperate with the relevant examinations of this project, and do not agree to sign the informed consent form.
Key Trial Info
Start Date :
March 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 18 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06565923
Start Date
March 18 2024
End Date
July 18 2025
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China